CTT Pharmaceutical Holdings, Inc.
CTTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001035422
In the last 90 days, CTT Pharmaceutical Holdings, Inc. insiders filed 14 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Market capNo recent closing price
- –
- Insider buysLast 90 days, $3.95K in total
- 14
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2014
- –
- No comparable prior period
- Net income, FY2014
- -$672.2K
- −708.5% year over year
- Free cash flow, FY2014
- –
- No comparable prior period
- Revenue, Q2 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 19.2K
- Shares sold short
- Change
- +1.00K
- +5.5% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding CTTH, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding CTTH at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by CTT Pharmaceutical Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 (view filing)9:45 AM ET | Nov 12 | 4 days | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +1.50K | $0.054 | +$81 | 0.0%9.45M after | |
| Nov 6, 2026 (view filing)11:13 AM ET | Nov 4 | 2 days | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +9.00K | $0.05 | +$450 | +0.1%9.45M after | |
| Oct 26, 2026 (view filing)9:05 PM ET | Oct 26 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +5.88K | $0.057 | +$335.16 | +0.1%9.44M after | |
| Oct 19, 2026 (view filing)5:22 PM ET | Oct 15 | 4 days | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +2.00K | $0.057 | +$114 | 0.0%9.44M after | |
| Oct 6, 2026 (view filing)5:24 PM ET | Oct 6 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +3.70K | $0.055 | +$203.5 | 0.0%9.43M after | |
| Sep 29, 2026 (view filing)10:22 AM ET | Sep 22 | 7 days | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +10.1K | $0.045 | +$454.5 | +0.1%9.42M after | Amended |
| Sep 28, 2026 (view filing)9:56 AM ET | Sep 28 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +3.40K | $0.055 | +$187 | 0.0%9.43M after | |
| Sep 16, 2026 (view filing)1:19 PM ET | Sep 16 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +10.9K | $0.048 | +$523.2 | +0.1%9.41M after | |
| Sep 10, 2026 (view filing)6:10 PM ET | Sep 10 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +3.50K | $0.05 | +$175 | 0.0%9.40M after | |
| Sep 4, 2026 (view filing)4:18 PM ET | Sep 4 | Same day | CTT Pharmaceutical Holdings, Inc.CEO | PPurchaseCTTH | +9.80K | $0.0489 | +$479.22 | +0.1%9.40M after |
Top 10 13F holders, Q2 2026
View all: Top 10 13F holders, Q2 2026The largest institutional positions in CTT Pharmaceutical Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding CTTH in 13F filings for Q2 2026.